Genetic Modification of T Cells Redirected towards CS1 Enhances Eradication of Myeloma Cells

PURPOSE: Our goal is to test if CS1 could be targeted by CAR T cells to treat MM. EXPERIMENTAL DESIGN: We generated a retroviral construct of a CS1-specific CAR and engineered primary human T cells expressing the CAR. We then tested the capacity of CS1-CAR T cells to eradicate human multiple myeloma...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chu, Jianhong, He, Shun, Deng, Youcai, Zhang, Jianying, Peng, Yong, Hughes, Tiffany, Yi, Ling, Kwon, Chang-Hyuk, Wang, Qi-En, Devine, Steven M, He, Xiaoming, Bai, Xue-Feng, Hofmeister, Craig C., Yu, Jianhua
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119545/
https://ncbi.nlm.nih.gov/pubmed/24677374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-2510
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares